Reported 1 day ago
In a recent lightning round, Jim Cramer discussed Tandem Diabetes Care, Inc. (NASDAQ:TNDM) after a caller mentioned their family's use of its products. Cramer acknowledged the challenges of the company, including financial losses, but encouraged younger investors to consider it as a speculative stock due to their long investment horizon and personal experience with the products.
Source: YAHOO